Net profit attributable to owners of the company recovered to $0.6 million from a loss of $2.9 million, supported by the Ebitda uplift and a reversal of impairment losses. Operating cash flow strengthened significantly to $4.3 million from $0.9 million, reflecting stronger earnings and working capital management.
SAC Capital has issued a non-rated report on multidisciplinary healthcare group Livingstone Health Holdings, as analyst Daniel Ng sees growth opportunities for the group following its FY2025 ended March earnings recovery.
In FY2025, Livingstone recorded a 9.0% y-o-y increase in revenue to $27.6 million, driven by growth across all business segments. Ebitda surged from $0.5 million to $2.9 million, with Ebitda margin expanding from 1.8% to 10.6% on higher revenue contribution and improved operating efficiency.
